Candidiasis, Invasive Recruiting Phase 3 Trials for MK-3118 (DB12471)

Also known as: Invasive Candidiasis / Systemic moniliasis / Systemic candida / Disseminated candidiasis / Disseminated candida / Systemic candidiasis

IndicationStatusPhase
DBCOND0036184 (Candidiasis, Invasive)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03363841Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)Treatment